09 LYG, which was less than 4
2 mg/kg/d in 2 Tacrolimus has an average rating of 8
[] Recent developments in the field of renal transplant including novel drugs have contributed
Treating 100 recipients with tacrolimus instead of cyclosporin would avoid Initial tacrolimus treatment showed better patient and graft survival than cyclosporine, with 10-year patient survival estimates of 72
8 percent (p<0
As an immunosuppressive agent, tacrolimus is approximately 100
In comparison with the existing drug cyclosporine, it was argued that tacrolimus was better in the control of acute rejection, although there was no difference in the survival rate of the
However, the advantage of
This study evaluated the effectiveness of early pre-emptive conversion from cyclosporine to tacrolimus in kidney transplant patients with normal graft function and in the absence of adverse effects of the initial cyclosporine
33 Low dose tacrolimus was significantly better than all other treatment arms in terms of BPAR
Want this question answered? Be notified when an answer is posted
It also presents a case report of a patient who developed severe hemolytic